GOT1 and neoplasm: Since AST/ALT ratio was found to be associated with tumor burden (Table 1), the prognosis of 81 mCRPC patients who progressed from mHSPC (high tumor volume n = 59, low tumor volume n = 22) was examined by combining tumor burden and AST/ALT ratio.